Biological and Clinical Significance of Endotoxemia in the Course of Hepatitis C Virus Infection
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
995-1005
Author(s):
L. Caradonna, M. L. Mastronardi, T. Magrone, R. Cozzolongo, R. Cuppone, O. G. Manghisi, D. Caccavo, N. M. Pellegrino, A. Amoroso, E. Jirillo and L. Amati
Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1013-1019
Author(s):
M. Stanzione, S. Pignata, M. Di Maio, E. De Maio, O. G. Manghisi, M. Felder, M. Persico, M. Russo, F. Castiglione, I De Sio, A. Aiello, D. Mattera, F. Perrone, M. Calandra, G. Piai, S. Elba, F. Farinati, R. Mazzanti, L. E. Adinolfi, G. Capuano, F. Izzo, G. B. Gaeta, B. Daniele and C. Gallo
Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
111-133
Author(s):
Andrea Amalfitano and Robin J. Parks
Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery
Journal:
Current Gene Therapy
Volume:
2
Page:
161-171
Author(s):
Peter Loser, Andreas Huser, Moritz Hillgenberg, Daniel Kumin, Gerald W. Both and Christian Hofimann
Bone Marrow Stromal Cells as Targets for Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
195-209
Author(s):
An Van Damme, Thierry Vanden Driessche, Desire Collen and Marinee K.L. Chuah
The Recombinant T Cell Receptor Strategy: Insights into Structure and Function of Recombinant Immunoreceptors on the Way Towards an Optimal Receptor Design for Cellular Immunotherapy
Journal:
Current Gene Therapy
Volume:
2
Page:
211-226
Author(s):
Andreas Hombach, Claudia Heuser and Hinrich Abken
Restoration of Transgene Expression in Hematopoietic Cells with Drug-Selectable Marker Genes
Journal:
Current Gene Therapy
Volume:
2
Page:
227-234
Author(s):
Thomas Licht and Chrisitian Peschel
Genetic Vaccination for the Immunotherapy of B-Cell Malignancies
Journal:
Current Gene Therapy
Volume:
2
Page:
235-242
Author(s):
F. Benvenuti and O. R. Burrone
Oncolytic Viruses: Programmable Tumour Hunters
Journal:
Current Gene Therapy
Volume:
2
Page:
243-254
Author(s):
J. C. Bell, K. A. Garson, B. D. Lichty and F. D. Stojdl
Manipulation of CD45 Antigen in Transplantation Tolerance
Journal:
Current Molecular Medicine
Volume:
2
Page:
249-255
Author(s):
Saiho Ko, Mark D. Jaeger, Marc H. Dahlke, Yoshiyuki Nakajima and Hans J. Schlitt